Skip to main content

Table 1 The treatment groups

From: Transcriptome investigation of anti‐inflammation and immuno‐regulation mechanism of taurochenodeoxycholic acid

Group

Treatment

TCDCA concentration (M)

AA rat FLS group (FCA group)

-

AA rat FLS + TCDCA high dose treatment (AT10 group)

1 × 10− 5

AA rat FLS + TCDCA medium dose treatment (AT1 group)

1 × 10− 6

AA rat FLS + TCDCA low dose treatment (AT01 group)

1 × 10− 7

  1. AA Adjuvant arthritis, FLS Fibroblast-like synoviocytes, TCDCA Taurochenodeoxycholic acid